Chempass Company
ChemPass was founded to develop AI technologies and software for the design of novel small organic molecules and scaffolds. ChemPass' technologies utilize synthetic artificial intelligence for template design, in silico reaction planning and evaluation, a chemistry know-how database and several other custom solutions.
%20.jpg)
Industry:
Drug Discovery
Investment Stage:
N/A
Investor Type:
N/A
Headquarters:
Budapest, Budapest, Hungary
Technology:
Drug Design
Funding Status:
Seed
Number Of Exists:
N/A
Founded Date:
2016
Employee Number:
Undisclosed